ERK1/2-dependent TSPO overactivation associates with the loss of mitophagy and mitochondrial respiration in ALS
Mitochondrial dysfunction and the loss of mitophagy, aimed at recycling irreversibly
damaged organelles, contribute to the onset of amyotrophic lateral sclerosis (ALS), a fatal …
damaged organelles, contribute to the onset of amyotrophic lateral sclerosis (ALS), a fatal …
Mitochondrial quality control in amyotrophic lateral sclerosis: towards a common pathway?
B Khalil, JC Liévens - Neural Regeneration Research, 2017 - journals.lww.com
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder
characterized by loss of upper and lower motor neurons. Different mechanisms contribute to …
characterized by loss of upper and lower motor neurons. Different mechanisms contribute to …
Mitochondria in amyotrophic lateral sclerosis: a trigger and a target
L Dupuis, JL Gonzalez de Aguilar, H Oudart… - Neurodegenerative …, 2005 - karger.com
Strong evidence shows that mitochondrial dysfunction is involved in amyotrophic lateral
sclerosis (ALS), but despite the fact that mitochondria play a central role in excitotoxicity …
sclerosis (ALS), but despite the fact that mitochondria play a central role in excitotoxicity …
ASCs-Exosomes Recover Coupling Efficiency and Mitochondrial Membrane Potential in an in vitro Model of ALS
E Calabria, I Scambi, R Bonafede… - Frontiers in …, 2019 - frontiersin.org
The amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized
by motoneurons death. Mutations in the superoxide dismutase 1 (SOD1) protein have been …
by motoneurons death. Mutations in the superoxide dismutase 1 (SOD1) protein have been …
[HTML][HTML] Mitochondrial dysfunction in amyotrophic lateral sclerosis
The etiology of motor neuron degeneration in amyotrophic lateral sclerosis (ALS) remains to
be better understood. Based on the studies from ALS patients and transgenic animal …
be better understood. Based on the studies from ALS patients and transgenic animal …
Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis
P Shi, Y Wei, J Zhang, J Gal… - Journal of Alzheimer's …, 2010 - content.iospress.com
A better understanding of the etiology of amyotrophic lateral sclerosis (ALS) is needed to
develop effective therapies for the treatment of this fatal neurodegenerative disease …
develop effective therapies for the treatment of this fatal neurodegenerative disease …
ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression
In amyotrophic lateral sclerosis (ALS), mitochondrial dysfunction and oxidative stress form a
vicious cycle that promotes neurodegeneration and muscle wasting. To quantify the disease …
vicious cycle that promotes neurodegeneration and muscle wasting. To quantify the disease …
Mitochondrial dysfunction and its role in motor neuron degeneration in ALS
G Manfredi, Z Xu - Mitochondrion, 2005 - Elsevier
Mitochondria play a pivotal role in many metabolic and apoptotic pathways that regulate the
life and death of cells. Accumulating evidence suggests that mitochondrial dysfunction is …
life and death of cells. Accumulating evidence suggests that mitochondrial dysfunction is …
Parkin is a disease modifier in the mutant SOD 1 mouse model of ALS
GM Palomo, V Granatiero, H Kawamata… - EMBO molecular …, 2018 - embopress.org
Abstract Mutant Cu/Zn superoxide dismutase (SOD 1) causes mitochondrial alterations that
contribute to motor neuron demise in amyotrophic lateral sclerosis (ALS). When …
contribute to motor neuron demise in amyotrophic lateral sclerosis (ALS). When …
[HTML][HTML] Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis
W Tan, P Pasinelli, D Trotti - … et Biophysica Acta (BBA)-Molecular Basis of …, 2014 - Elsevier
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with an adult onset
characterized by loss of both upper and lower motor neurons. In~ 10% of cases, patients …
characterized by loss of both upper and lower motor neurons. In~ 10% of cases, patients …